ATE539737T1
Nanoparticulate megestrol formulations
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 14 April 2023, 3.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
59 members in 18 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 37168002 | United States of America | P | |
| 43034802 | United States of America | P | |
| 0311277 | United States of America | W |
Members59
| Document | Office | Kind | |
|---|---|---|---|
| CA2481390A1 | Canada | A1 | |
| WO03086354A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003230885A1 | Australia | A1 | |
| US2003219490A1 | United States of America | A1 | |
| US2004105889A1 | United States of America | A1 | |
| CA2508301A1 | Canada | A1 | |
| WO2004050059A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003231071A1 | Australia | A1 | |
| EP1494649A1 | European Patent Office (EPO) | A1 | |
| US2005008707A1 | United States of America | A1 | |
| JP2005527584A | Japan | A | |
| US2005233001A1 | United States of America | A1 | |
| EP1613276A1 | European Patent Office (EPO) | A1 | |
| JP2006510726A | Japan | A | |
| US7101576B2 | United States of America | B2 | |
| AU2006262144A1 | Australia | A1 | |
| CA2613466A1 | Canada | A1 | |
| WO2007002315A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007002315A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20080024213A | Republic of Korea | A | |
| NO20080403L | Norway | L | |
| EP1901713A2 | European Patent Office (EPO) | A2 | |
| IL188322A0 | Israel | A0 | |
| EP1935407A1 | European Patent Office (EPO) | A1 | |
| US2008152585A1 | United States of America | A1 | |
| EA200800099A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2008171088A1 | United States of America | A1 | |
| CN101242810A | China | A | |
| JP2008546796A | Japan | A | |
| MX2008000396A | Mexico | A | |
| ZA200800376B | South Africa | B | |
| US2010226989A1 | United States of America | A1 | |
| US2010266705A1 | United States of America | A1 | |
| JP2010248220A | Japan | A | |
| BRPI0612665A2 | Brazil | A2 | |
| EP2263650A2 | European Patent Office (EPO) | A2 | |
| EP2263651A2 | European Patent Office (EPO) | A2 | |
| EP2263651A3 | European Patent Office (EPO) | A3 | |
| JP4838514B2 | Japan | B2 | |
| JP2011251989A | Japan | A | |
| EP1494649B1 | European Patent Office (EPO) | B1 | |
| AT539737T | Austria | T | |
| ATE539737T1This record | Austria | T1 | |
| JP4865990B2 | Japan | B2 | |
| DK1494649T3 | Denmark | T3 | |
| PT1494649E | Portugal | E | |
| US2012087955A1 | United States of America | A1 | |
| ES2380318T3 | Spain | T3 | |
| CA2481390C | Canada | C | |
| US2013251805A1 | United States of America | A1 | |
| EP2263650A3 | European Patent Office (EPO) | A3 | |
| US2015056286A1 | United States of America | A1 | |
| US2015056287A1 | United States of America | A1 | |
| US2015086635A1 | United States of America | A1 | |
| US9040088B2 | United States of America | B2 | |
| US9101540B2 | United States of America | B2 | |
| US9101549B2 | United States of America | B2 | |
| US9107827B2 | United States of America | B2 | |
| US2015320682A1 | United States of America | A1 |
Numbers
- Application
- 3723991
Titles2
- German
- NANOPARTIKULÄRE MEGESTROL- FORMULIERUNGEN
- English
- NANOPARTICULAR MEGESTROL FORMULATIONS
Classification
- CPC, 12
- A61K9/0095
- A61K9/145
- A61K9/146
- A61K31/57
- A61K45/06
- A61K47/32
- A61K47/38
- A61P15/08
- A61P15/18
- A61P17/00
- A61P31/18
- A61P35/00
- IPC, 25
- A61K9 00
- A61K9 14
- A61K31 57
- A61K45 00
- A61K45 06
- A61K47 10
- A61K47 12
- A61K47 14
- A61K47 18
- A61K47 20
- A61K47 22
- A61K47 24
- A61K47 26
- A61K47 28
- A61K47 32
- A61K47 34
- A61K47 36
- A61K47 38
- A61K47 42
- A61K47 44
- A61P15 08
- A61P15 18
- A61P17 00
- A61P31 18
- A61P35 00